DANA Inc financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data DANA Inc files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	5,826	7,209	8,143	8,620	7,106	8,945	10,156	7,613	7,734	7,500
Cost of revenue	4,991	6,143	6,986	7,489	6,485	8,108	9,393	7,236	7,356	6,898
Gross profit	835	1,066	1,157	1,131	621	837	763	377	378	602
Research and development	81	102	103	112	146	178	201	196	184	105
Selling, general and administrative	401	508	499	508	421	460	495	440	429	387
Operating income	332	490	579	292	124	395	86	-108	-176	139
Interest expense	113	102	96	122	138	131	128	152	158	181
Interest income	13	11	11	10	9	9	11	15	13	10
Other non-operating income	9	9
Pre-tax income	215	380	494	171	-13	244	-31	-246	-321	-32
Income tax	-424	283	78	-32	58	72	284	7	31	53
Income from continuing operations								-272	-350	-70
Net income to minority interests	13
Net income	640	111	427	226	-31	197	-242	38	-57	85
EBITDA	505	710	839	614	469	760	451	191	161	484
EPS, basic	4.38	0.72	2.94	1.57	-0.21	1.36	-1.69	0.26	-0.39	0.64
EPS, diluted	4.36	0.71	2.91	1.56	-0.21	1.35	-1.69	0.26	-0.39	0.64
Shares, basic (weighted)	146	145	145	144	145	145	144	144	145	134
Shares, diluted (weighted)	147	147	147	145	145	146	144	144	145	134
Dividend per share	0.24	0.24	0.40	0.40	0.10	0.40	0.40	0.40	0.40	0.40

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	707	603	510	508	559	268	425	529	494	469
Short-term investments		40	21	19	21	17
Receivables	721	994	1,065	1,103	1,201	1,321	1,374	1,371	890	987
Inventory	638	969	1,031	1,193	1,149	1,564	1,609	1,676	1,047	1,015
Other current assets	78	97	102	137	127	196	219	200	130	114
Total current assets	2,284	2,882	2,907	3,162	3,288	3,586	3,829	4,103	3,704	3,868
Property, plant and equipment	1,413	1,807	1,850	2,265	2,251	2,199	2,193	1,899	1,830	1,872
Lease right-of-use assets				178	190	247	311	286	260	305
Goodwill	90	127	264	493	479	482	259	263	250
Intangible assets	109	174	164	240	236	233	201	100	80	71
Long-term investments				0	49	0
Other non-current assets	226	71	80	120	169	131	123	101	118	102
Total assets	4,860	5,644	5,918	7,220	7,376	7,632	7,449	7,948	7,486	7,808
Accounts payable	819	1,165	1,217	1,255	1,331	1,571	1,838	1,198	1,120	1,154
Accrued liabilities	201	220	269	262	308	304	277	373	314	495
Deferred revenue	6	12	12	23	27	34	48	50	6	25
Short-term debt	69	40	20	20	8	8	8	35	214	30
Total current liabilities	1,253	1,702	1,747	1,845	1,941	2,174	2,479	2,602	2,561	3,308
Long-term debt	1,595	1,759	1,755	2,336	2,420	2,386	2,348	2,598	2,387	2,566
Lease liabilities				140	154	209	277	284	235	266
Other non-current liabilities	205	413	313	305	368	292	249	319	322	337
Total liabilities	3,618	4,483	4,376	5,085	5,362	5,459	5,651	6,137	5,901	6,909
Total debt	1,595	1,782	1,775	2,356	2,428	2,394	2,356	2,633	2,601	2,596
Paid-in capital	2,327	2,354	2,368	2,386	2,408	2,427	2,229	2,255	2,282	1,671
Retained earnings	195	86	456	622	530	662	321	317	204	235
Treasury stock	-83	-87	-119	-150	-156	-184	0	-9	-13	-35
Other comprehensive income	-1,284	-1,342	-1,362	-987	-1,026	-985	-1,001	-990	-1,142	-1,032
Shareholders' equity	1,157	1,013	1,345	1,873	1,758	1,922	1,551	1,575	1,333	840
Minority interests	85	101	97	95	76	53	52	62	63	59
Total equity	1,242	1,114	1,442	1,968	1,834	1,975	1,603	1,637	1,396	899
Total liabilities and equity	4,860	5,644	5,918	7,220	7,376	7,632	7,449	7,965	7,486	7,808
Shares outstanding	144	145	145	144	145	144	143	144	145	112

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	653	116	440	233	-51	200	-311	48	-49	102
Depreciation and amortization	173	220	260	322	345	365	365	299	337	345
Stock-based compensation	17	23	16	19	14	17	19	26	30	40
Deferred income tax	-480	179	-64	-137	-35	-1	153	-99	-76	-60
Change in receivables	-86	-141	-113	134	-66	-189	-81	-63	-14	-47
Change in inventory	-13	-146	-110	35	69	-471	-99	-37	-11	78
Change in payables	70	234	97	-96	82	254	343	-80	-5	-13
Cash from operations	384	554	568	637	386	158	649	476	450	512
Capital expenditures	-322	-393	-325	-426	-326	-369	-440	-427	-312	-214
Acquisitions	-78	-185	-153	-668	-6	-18	-1
Purchases of investments			-37	-33	-44	-32	-15
Sales and maturities of investments	47	27	37	29	36
Cash from investing	-365	-583	-462	-1,123	-327	-293	-426	-528	-352	-222
Debt issued	441	676		975	508	1,157	2	458	1
Debt repaid	-382	-640	-13	-423	-480	-1,156	-24	-209	-37	-223
Stock issued	2	10	2			5		3
Share buybacks	-81		-25	-25		-23	-25			-650
Dividends paid	-35	-35	-58	-58	-15	-58	-58	-58	-58	-54
Cash from financing	-88	-120	-180	479	-12	-127	-42	160	-90	-371
Exchange rate effect	-15	43	-16	5
Net change in cash		-149	-74	-7	47	-262	181	108	8	-81
Free cash flow	62	161	243	211	60	-211	209	49	138	298
Interest paid	111	104	90	117	129	109	117	126	156	170
Income taxes paid	89	87	145	125	98	99	132	92	100	96

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $27.14 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	9.5%	Gross profit / revenue.
Operating margin	2.7%	Operating income / revenue.
EBITDA margin	7.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	1.0%	Pre-tax income / revenue.
Net margin	14.6%	Net income / revenue.
FCF margin	1.5%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	5.6%	Cash from operations / revenue.
Effective tax rate	157.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	58.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	18.2%	Net income / average total assets.
Return on invested capital (ROIC)	5.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	5.1%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.5%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	4.1%	Capital expenditures / revenue.
D&A / revenue	4.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-3.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-9.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	1.1%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	59.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-7.6%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-0.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 3y	17.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	2.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	200.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	2.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	0.6%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	13.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-7.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	5.8%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	115.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	12.6%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	37.8%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	32.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-37.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-18.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-13.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	4.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	1.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	1.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-7.9%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.49x	Current assets / current liabilities.
Quick ratio	0.75x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.15x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.70x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	22.0%	Total debt / total assets.
Liabilities / assets	67.6%	Total liabilities / total assets.
Net debt	$1.01B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.84x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	1.49x	Operating income / interest expense.
Working capital	$1.05B	Current assets - current liabilities.
Goodwill and intangibles / assets	0.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	$1.86B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.25x	Revenue / average total assets.
Fixed asset turnover	3.95x	Revenue / average property, plant and equipment.
Inventory turnover	7.08x	Cost of revenue / average inventory.
Days inventory	52 days	365 x average inventory / cost of revenue.
Receivables turnover	5.95x	Revenue / average receivables.
Days sales outstanding	61 days	365 x average receivables / revenue.
Days payables	68 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	44 days	Days inventory + days sales outstanding - days payables.
FCF conversion	10.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	72.9%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$10.05	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$69.97	Revenue / diluted weighted shares.
FCF per share	$1.07	Free cash flow / diluted weighted shares.
Operating cash flow per share	$3.94	Cash from operations / diluted weighted shares.
Book value per share	$17.85	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$17.31	Tangible book value / shares outstanding.
Cash per share	$3.08	(Cash + short-term investments) / shares outstanding.
Payout ratio	4.6%	Dividends paid / net income, when net income is positive.
Dividends / FCF	43.6%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	480.3%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$2.92B	Share price x shares outstanding.
Enterprise value	$3.93B	Market cap + total debt - cash - short-term investments.
P/E	2.62x	Market cap / net income. Only when net income is positive.
P/S	0.38x	Market cap / revenue.
P/B	1.52x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.57x	Market cap / tangible book value, when positive.
P/FCF	25.0x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	6.77x	Market cap / cash from operations, when positive.
EV/Sales	0.51x	Enterprise value / revenue.
EV/EBIT	18.7x	Enterprise value / operating income, when both are positive.
EV/EBITDA	7.15x	Enterprise value / EBITDA, when both are positive.
EV/FCF	33.6x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.0%	Free cash flow / market cap.
Earnings yield	38.2%	Net income / market cap (the inverse of P/E).
Dividend yield	1.7%	Dividends paid over the period / market cap.
Shareholder yield	21.0%	(Dividends paid + share buybacks) / market cap.

What was DANA Inc's revenue in fiscal 2025?

DANA Inc reported revenue of $7.50B for fiscal 2025, 3% lower than the year before.

Was DANA Inc profitable in fiscal 2025?

Yes. Net income was $85.0M, a net margin of 1.1%.

How much free cash flow did DANA Inc generate in fiscal 2025?

Cash from operations of $512.0M minus capital expenditures of $214.0M left free cash flow of $298.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to DANA Inc